Curcumin Inhibits Platelet-Derived Growth Factor–Stimulated Vascular Smooth Muscle Cell Function and Injury-Induced Neointima Formation

Objective—Vascular smooth muscle cell (VSMC) migration, proliferation, and collagen synthesis are key events involved in the pathogenesis of cardiovascular disease. Growth factors, such as platelet-derived growth factor (PDGF) and fibroblast growth factor, released during vascular injury plays a pivotal role in regulating these events. Curcumin (diferuloyl methane), a major component of the spice turmeric (Curcuma longa), has been shown recently to have beneficial effects in chronic conditions, such as inflammation, cancer, cystic fibrosis, and Alzheimer’s disease. The objective of this study was to investigate the ability of curcumin to inhibit PDGF-stimulated migration, proliferation, and collagen synthesis in cultured VSMCs and neointima formation after carotid artery injury in rats. Methods and Results—Curcumin (1 to 25 &mgr;M) produced a concentration-dependent inhibition of PDGF-elicited VSMC migration, proliferation, and collagen synthesis assessed by chemotaxis, [3H]thymidine incorporation, and [3H]-l-proline incorporation, respectively. Curcumin blocked PDGF-induced VSMC actin-cytoskeleton reorganization, attenuated PDGF signal transduction, and inhibited the binding of PDGF to its receptors. Carotid artery neointima formation was significantly attenuated by perivascular curcumin compared with vehicle controls 14 days after injury, characterized by reduced DNA synthesis, collagen synthesis, and PDGF receptor phosphorylation. Conclusions—These data suggest that curcumin is a potent inhibitor of key PDGF-stimulated VSMC functions and may play a critical role in regulating these events after vascular injury.

[1]  A. Maggioni,et al.  Starc II, a multicenter randomized placebo‐controlled double‐blind clinical trial of trapidil for 1‐year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[2]  Min-Gon Kim,et al.  Zedoariae rhizoma and curcumin inhibits platelet-derived growth factor-induced proliferation of human hepatic myofibroblasts. , 2005, International immunopharmacology.

[3]  V. Kalra,et al.  Curcumin, the active constituent of turmeric, inhibits amyloid peptide‐induced cytochemokine gene expression and CCR5‐mediated chemotaxis of THP‐1 monocytes by modulating early growth response‐1 transcription factor , 2004, Journal of neurochemistry.

[4]  B. Aggarwal,et al.  Role of chemopreventive agents in cancer therapy. , 2004, Cancer letters.

[5]  Y. Gho,et al.  Synthetic curcumin analogs inhibit activator protein-1 transcription and tumor-induced angiogenesis. , 2004, Biochemical and biophysical research communications.

[6]  A. Nanji,et al.  Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-kappa B-dependent genes. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[7]  A. Masamune,et al.  Differential roles of signaling pathways for proliferation and migration of rat pancreatic stellate cells. , 2003, The Tohoku journal of experimental medicine.

[8]  D. Tulis,et al.  Adenoviral Gene Transfer of Fortilin Attenuates Neointima Formation Through Suppression of Vascular Smooth Muscle Cell Proliferation and Migration , 2003, Circulation.

[9]  N. Sreejayan,et al.  Protein-tyrosine Phosphatase-1B (PTP1B) Mediates the Anti-migratory Actions of Sprouty* , 2003, The Journal of Biological Chemistry.

[10]  J. Wood,et al.  Pharmacology of imatinib (STI571). , 2002, European journal of cancer.

[11]  N. Sreejayan,et al.  NO Attenuates Insulin Signaling and Motility in Aortic Smooth Muscle Cells via Protein Tyrosine Phosphatase 1B–Mediated Mechanism , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[12]  G. Cole,et al.  The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse , 2001, The Journal of Neuroscience.

[13]  W. Durante,et al.  Heme oxygenase-1 attenuates vascular remodeling following balloon injury in rat carotid arteries. , 2001, Atherosclerosis.

[14]  V. Steele,et al.  Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. , 2000, The Journal of nutrition.

[15]  A. Hassid,et al.  Nitric oxide and C-type atrial natriuretic peptide stimulate primary aortic smooth muscle cell migration via a cGMP-dependent mechanism: relationship to microfilament dissociation and altered cell morphology. , 1999, Circulation research.

[16]  C. Heldin,et al.  Mechanism of action and in vivo role of platelet-derived growth factor. , 1999, Physiological reviews.

[17]  R. Nagai,et al.  Effect of Probucol on Smooth Muscle Cell Proliferation and Dedifferentiation After Vascular Injury in Rabbits: Possible Role of PDGF , 1998, Cardiovascular Drugs and Therapy.

[18]  E. Edelman,et al.  Antisense oligonucleotide inhibition of PDGFR-beta receptor subunit expression directs suppression of intimal thickening. , 1997, Circulation.

[19]  K. Kent,et al.  Differential effects of platelet-derived growth factor isotypes on human smooth muscle cell proliferation and migration are mediated by distinct signaling pathways. , 1996, Surgery.

[20]  N. Sreejayan,et al.  Free radical scavenging activity of curcuminoids. , 1996, Arzneimittel-Forschung.

[21]  K. Hedberg,et al.  The effect of neomycin on PDGF-induced mitogenic response and actin organization in cultured human fibroblasts. , 1995, Experimental cell research.

[22]  M. Rao,et al.  Curcuminoids as Potent Inhibitors of Lipid Peroxidation , 1994, The Journal of pharmacy and pharmacology.

[23]  P. Armstrong,et al.  Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. , 1994, Circulation research.

[24]  R. Chioin,et al.  The trapidil restenosis trial (STARC study): background, methods and clinical characteristics of the patient population. , 1994, Clinical trials and meta-analysis.

[25]  R. Ross The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[26]  E J Topol,et al.  The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. , 1992, Journal of the American College of Cardiology.

[27]  M. Reidy,et al.  Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF , 1991, Science.

[28]  H. Ammon,et al.  Pharmacology of Curcuma longa , 1991, Planta medica.

[29]  S. Schwartz,et al.  PDGF ligand and receptor gene expression during repair of arterial injury , 1990, The Journal of cell biology.

[30]  D. Faxon,et al.  Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981. The National Heart, Lung, and Blood Institute Registry. , 1988, The New England journal of medicine.

[31]  J. Milner,et al.  Micronutrients in Cancer Chemoprevention , 2004, Cancer and Metastasis Reviews.

[32]  M. Pirmohamed,et al.  Phase I Clinical Trial of Oral Curcumin: Biomarkers of Systemic Activity and Compliance , 2004 .

[33]  Clinical development plan: Curcumin , 2002 .

[34]  E. Jackson,et al.  Adenosine inhibits growth of human aortic smooth muscle cells via A2B receptors. , 1998, Hypertension.